These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22508742)

  • 1. ACP Journal Club. Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality.
    Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-02. PubMed ID: 22508742
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Prostate cancer screening using PSA does not decrease mortality.
    Luckmann R
    Ann Intern Med; 2011 Jan; 154(2):JC1-2. PubMed ID: 21242356
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality.
    Hoffman RM
    Ann Intern Med; 2012 Jul; 157(2):JC2-4. PubMed ID: 22801696
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Annual screening for prostate cancer did not reduce mortality from prostate cancer.
    Canfield SE
    Ann Intern Med; 2009 Jun; 150(12):JC6-4, JC6-5. PubMed ID: 19528549
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Population-based screening using prostate-specific antigen testing reduced prostate cancer mortality.
    Hoffman RM
    Ann Intern Med; 2010 Dec; 153(12):JC6-9. PubMed ID: 21173410
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: General health checks in adults do not reduce all-cause, cardiovascular, or cancer mortality.
    Lim LS
    Ann Intern Med; 2013 Jan; 158(2):JC2. PubMed ID: 23318336
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Periodic screening with prostate-specific antigen testing reduced mortality from prostate cancer.
    Canfield SE
    Ann Intern Med; 2009 Jun; 150(12):JC6-5, JC6-4. PubMed ID: 19528550
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality.
    Fedorkow D
    Ann Intern Med; 2011 Sep; 155(6):JC3-8. PubMed ID: 21930845
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-04, JC4-05. PubMed ID: 22508744
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACP Journal Club. Screening with chest radiography did not reduce lung cancer mortality in older patients.
    Lacasse Y
    Ann Intern Med; 2012 Mar; 156(6):JC3-8. PubMed ID: 22431694
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Screening with spiral CT did not reduce lung cancer mortality in older male smokers.
    Bezjak A
    Ann Intern Med; 2009 Dec; 151(12):JC6-11. PubMed ID: 20008747
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Review: Aspirin does not reduce CHD or cancer mortality but increases bleeding.
    Rembold CM
    Ann Intern Med; 2012 Jun; 156(12):JC6-3. PubMed ID: 22711104
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: CT screening for lung cancer reduced mortality in 1 large trial but not in 2 smaller trials.
    Neugut AI; Accordino MK
    Ann Intern Med; 2012 Sep; 157(6):JC3-6. PubMed ID: 22986398
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACP Journal Club. Review: In women 39 to 69 years of age, screening with mammography reduces breast cancer mortality.
    Willett LR
    Ann Intern Med; 2010 Feb; 152(4):JC-27. PubMed ID: 20157131
    [No Abstract]   [Full Text] [Related]  

  • 17. Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.
    Connolly D; Black A; Gavin A; Keane PF; Murray LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):271-8. PubMed ID: 18250343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACP Journal Club. Radical prostatectomy and observation did not differ for mortality in localized prostate cancer.
    Dahm P; Gilbert S
    Ann Intern Med; 2012 Oct; 157(8):JC4-5. PubMed ID: 23070507
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACP Journal Club. Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate cancer.
    Stockler MR
    Ann Intern Med; 2013 Jan; 158(2):JC9. PubMed ID: 23318343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.